BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33807494)

  • 21. Patient survival prediction in locally advanced cervical squamous cell carcinoma using MRI-based radiomics: retrospective cohort study.
    Bseiso A; Saqib M; Saigol MS; Rehman A; Sare A; Yagoub AE; Mumtaz H
    Ann Med Surg (Lond); 2023 Nov; 85(11):5328-5336. PubMed ID: 37915655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study.
    Petresc B; Lebovici A; Caraiani C; Feier DS; Graur F; Buruian MM
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics.
    Bulens P; Couwenberg A; Intven M; Debucquoy A; Vandecaveye V; Van Cutsem E; D'Hoore A; Wolthuis A; Mukherjee P; Gevaert O; Haustermans K
    Radiother Oncol; 2020 Jan; 142():246-252. PubMed ID: 31431368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the "PRICE" study 2: role of conventional and DW-MRI.
    Gui B; Miccò M; Valentini AL; Cambi F; Pasciuto T; Testa A; Autorino R; Zannoni GF; Rufini V; Gambacorta MA; Giordano A; Scambia G; Manfredi R
    Eur Radiol; 2019 Apr; 29(4):2045-2057. PubMed ID: 30324389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery.
    Gui B; Valentini AL; Miccò M; D'Agostino GR; Tagliaferri L; Zannoni GF; Fanfani F; Manfredi R; Bonomo L
    Acta Radiol; 2016 Sep; 57(9):1123-31. PubMed ID: 26622060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
    Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
    Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
    JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
    West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
    Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
    Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
    Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
    Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
    Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 37. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.
    Horvat N; Veeraraghavan H; Khan M; Blazic I; Zheng J; Capanu M; Sala E; Garcia-Aguilar J; Gollub MJ; Petkovska I
    Radiology; 2018 Jun; 287(3):833-843. PubMed ID: 29514017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
    Lucia F; Visvikis D; Vallières M; Desseroit MC; Miranda O; Robin P; Bonaffini PA; Alfieri J; Masson I; Mervoyer A; Reinhold C; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):864-877. PubMed ID: 30535746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
    Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive prediction of lymph node status for patients with early-stage cervical cancer based on radiomics features from ultrasound images.
    Jin X; Ai Y; Zhang J; Zhu H; Jin J; Teng Y; Chen B; Xie C
    Eur Radiol; 2020 Jul; 30(7):4117-4124. PubMed ID: 32078013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.